Teresa Rasalan

3.6k total citations · 1 hit paper
17 papers, 1.2k citations indexed

About

Teresa Rasalan is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Teresa Rasalan has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Teresa Rasalan's work include T-cell and B-cell Immunology (10 papers), Immunotherapy and Immune Responses (10 papers) and vaccines and immunoinformatics approaches (5 papers). Teresa Rasalan is often cited by papers focused on T-cell and B-cell Immunology (10 papers), Immunotherapy and Immune Responses (10 papers) and vaccines and immunoinformatics approaches (5 papers). Teresa Rasalan collaborates with scholars based in United States and Japan. Teresa Rasalan's co-authors include Jianda Yuan, Jedd D. Wolchok, Humilidad F. Gallardo, Stephanie Terzulli, Katherine S. Panageas, Yinyan Xu, Lloyd J. Old, James P. Allison, Achim A. Jungbluth and Sacha Gnjatic and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Teresa Rasalan

17 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Integrated NY-ESO-1 antibody and CD8⁺T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

2011 254 citations Jianda Yuan, Matthew Adamow et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Teresa Rasalan United States	12	953	742	293	77	77	17	1.2k
Daniel Hirschhorn-Cymerman United States	15	1.4k 1.4×	979 1.3×	272 0.9×	57 0.7×	87 1.1×	22	1.7k
Aalok Kacha United States	6	1.2k 1.3×	834 1.1×	332 1.1×	60 0.8×	81 1.1×	9	1.5k
Jianping Yang New Zealand	20	822 0.9×	403 0.5×	256 0.9×	110 1.4×	55 0.7×	44	1.1k
Hamid Echchakir France	19	811 0.9×	463 0.6×	263 0.9×	44 0.6×	60 0.8×	29	1.2k
David Oppenheim United Kingdom	9	1.1k 1.2×	530 0.7×	144 0.5×	47 0.6×	35 0.5×	11	1.3k
Robin Pennington United States	10	896 0.9×	486 0.7×	334 1.1×	37 0.5×	71 0.9×	12	1.2k
Jean‐Paul Rivals Switzerland	12	774 0.8×	461 0.6×	186 0.6×	38 0.5×	64 0.8×	16	1.1k
S. Schwarz United States	6	646 0.7×	468 0.6×	231 0.8×	57 0.7×	159 2.1×	12	977
Sarah J. Flies United States	7	864 0.9×	773 1.0×	150 0.5×	93 1.2×	30 0.4×	7	1.2k
Ainhoa Pérez‐Díez United States	15	884 0.9×	530 0.7×	407 1.4×	25 0.3×	122 1.6×	27	1.2k

Countries citing papers authored by Teresa Rasalan

Since Specialization

Citations

This map shows the geographic impact of Teresa Rasalan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa Rasalan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa Rasalan more than expected).

Fields of papers citing papers by Teresa Rasalan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teresa Rasalan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa Rasalan. The network helps show where Teresa Rasalan may publish in the future.

Co-authorship network of co-authors of Teresa Rasalan

This figure shows the co-authorship network connecting the top 25 collaborators of Teresa Rasalan. A scholar is included among the top collaborators of Teresa Rasalan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teresa Rasalan. Teresa Rasalan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

O’Cearbhaill, Roisin E., Sacha Gnjatic, Carol Aghajanian, et al.. (2018). A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ ovarian cancer (OC) in second or third remission.. Journal of Clinical Oncology. 36(15_suppl). 5553–5553. 6 indexed citations

2.

Kitano, Shigehisa, Michael A. Postow, Carly G.K. Ziegler, et al.. (2014). Computational Algorithm-Driven Evaluation of Monocytic Myeloid-Derived Suppressor Cell Frequency for Prediction of Clinical Outcomes. Cancer Immunology Research. 2(8). 812–821. 111 indexed citations

3.

Kitano, Shigehisa, Michael A. Postow, Czrina Cortez, et al.. (2012). Myeloid-derived suppressor cell quantity prior to treatment with ipilimumab at 10mg/kg to predict for overall survival in patients with metastatic melanoma.. Journal of Clinical Oncology. 30(15_suppl). 2518–2518. 24 indexed citations

4.

Perales, Miguel‐Angel, Jeffrey L. Goldberg, Jianda Yuan, et al.. (2012). Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation. Blood. 120(24). 4882–4891. 140 indexed citations

5.

Yuan, Jianda, Matthew Adamow, Brian Ginsberg, et al.. (2011). Integrated NY-ESO-1 antibody and CD8⁺T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab. Proceedings of the National Academy of Sciences. 108(40). 16723–16728. 254 indexed citations breakdown →

6.

Yuan, Jianda, Brian Ginsberg, David B. Page, et al.. (2011). CTLA-4 blockade increases antigen-specific CD8+ T cells in prevaccinated patients with melanoma: three cases. Cancer Immunology Immunotherapy. 60(8). 1137–1146. 71 indexed citations

7.

Perales, Miguel‐Angel, Jeffrey L. Goldberg, Jianda Yuan, et al.. (2011). Recombinant Human Interleukin-7 (CYT107) Promotes T Cell Recovery Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantion. Biology of Blood and Marrow Transplantation. 17(2). S234–S234. 1 indexed citations

8.

Perales, Miguel‐Angel, Jenna D. Goldberg, Jianda Yuan, et al.. (2010). Recombinant Human Interleukin-7 (CYT107) Enhances CD4 and CD8 T Cell Recovery Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant In Patients with Myeloid Malignancies. Blood. 116(21). 674–674. 2 indexed citations

9.

Ginsberg, Brian, Humilidad F. Gallardo, Teresa Rasalan, et al.. (2010). Immunologic Response to Xenogeneic gp100 DNA in Melanoma Patients: Comparison of Particle-Mediated Epidermal Delivery with Intramuscular Injection. Clinical Cancer Research. 16(15). 4057–4065. 39 indexed citations

10.

Lin, Yun, Humilidad F. Gallardo, Geoffrey Y. Ku, et al.. (2009). Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses. Cytotherapy. 11(7). 912–922. 29 indexed citations

11.

Lin, Yun, Humilidad F. Gallardo, Geoffrey Y. Ku, et al.. (2009). Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses. Cytotherapy. 1–11. 3 indexed citations

12.

Yuan, Jianda, Geoffrey Y. Ku, Humilidad F. Gallardo, et al.. (2009). Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma.. PubMed. 9. 5–5. 62 indexed citations

13.

Perales, Miguel‐Angel, Jianda Yuan, Humilidad F. Gallardo, et al.. (2008). Phase I/II Study of GM-CSF DNA as an Adjuvant for a Multipeptide Cancer Vaccine in Patients With Advanced Melanoma. Molecular Therapy. 16(12). 2022–2029. 76 indexed citations

14.

Yuan, Jianda, Sacha Gnjatic, Hao Li, et al.. (2008). CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit. Proceedings of the National Academy of Sciences. 105(51). 20410–20415. 267 indexed citations

15.

Wolchok, Jedd D., Jianda Yuan, Alan N. Houghton, et al.. (2007). Safety and Immunogenicity of Tyrosinase DNA Vaccines in Patients with Melanoma. Molecular Therapy. 15(11). 2044–2050. 76 indexed citations

16.

Wolchok, Jedd D., Humilidad F. Gallardo, Miguel‐Angel Perales, et al.. (2007). Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma. Journal of Clinical Oncology. 25(18_suppl). 3005–3005. 2 indexed citations

17.

Yuan, Jianda, Humilidad F. Gallardo, Teresa Rasalan, et al.. (2006). In vitro expansion of Ag-specific T cells by HLA-A*0201-transfected K562 cells for immune monitoring. Cytotherapy. 8(5). 498–508. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact